Reduced Insular Glutamine and N-acetylaspartate in systemic lupus erythematosus: a single-voxel (1)H-MR spectroscopy study.

[1]  M. van Buchem,et al.  Neuropsychiatric manifestations in patients with systemic lupus erythematosus: epidemiology and radiology pointing to an immune-mediated cause , 2012, Annals of the rheumatic diseases.

[2]  T. Chenevert,et al.  Perfusion-weighted MR imaging in cerebral lupus erythematosus. , 2012, Academic radiology.

[3]  P. Sundgren,et al.  Posterior Insular Molecular Changes in Myofascial Pain , 2012, Journal of dental research.

[4]  D. Miller,et al.  Memory impairment associated with neurometabolic abnormalities of the hippocampus in patients with non-neuropsychiatric systemic lupus erythematosus , 2011, Lupus.

[5]  P. Renshaw,et al.  Brain metabolite concentrations across cortical regions in healthy adults , 2011, Brain Research.

[6]  C. Gasparovic,et al.  Elevated Cerebral Blood Flow and Volume in Systemic Lupus Measured by Dynamic Susceptibility Contrast Magnetic Resonance Imaging , 2010, The Journal of Rheumatology.

[7]  M. van Buchem,et al.  Perfusion MRI in neuro‐psychiatric systemic lupus erthemathosus , 2010, Journal of magnetic resonance imaging : JMRI.

[8]  B. Hart,et al.  Magnetic resonance imaging and brain histopathology in neuropsychiatric systemic lupus erythematosus. , 2010, Seminars in arthritis and rheumatism.

[9]  G. Lemke,et al.  Disturbed distribution of proliferative brain cells during lupus-like disease , 2009, Brain, Behavior, and Immunity.

[10]  Vitaly Napadow,et al.  Elevated insular glutamate in fibromyalgia is associated with experimental pain. , 2009, Arthritis and rheumatism.

[11]  Peter T Fox,et al.  Brain Magnetic Resonance Imaging in Newly Diagnosed Systemic Lupus Erythematosus , 2008, The Journal of Rheumatology.

[12]  Simone Appenzeller,et al.  Magnetic Resonance Imaging in the Evaluation of Central Nervous System Manifestations in Systemic Lupus Erythematosus , 2008, Clinical reviews in allergy & immunology.

[13]  J. Hoogduin,et al.  Reproducibility over a 1-month period of 1H-MR spectroscopic imaging NAA/Cr ratios in clinically stable multiple sclerosis patients , 2008, European Radiology.

[14]  Daniel J Clauw,et al.  Dynamic levels of glutamate within the insula are associated with improvements in multiple pain domains in fibromyalgia. , 2008, Arthritis and rheumatism.

[15]  F. Cendes,et al.  Neurometabolic changes in normal white matter may predict appearance of hyperintense lesions in systemic lupus erythematosus , 2007, Lupus.

[16]  J. Sánchez-Guerrero,et al.  Interleukin-6 and chemokines in the neuropsychiatric manifestations of systemic lupus erythematosus. , 2007, Arthritis and rheumatism.

[17]  J. Moffett,et al.  N-Acetylaspartate in the CNS: From neurodiagnostics to neurobiology , 2007, Progress in Neurobiology.

[18]  Li Min Li,et al.  Evidence of reversible axonal dysfunction in systemic lupus erythematosus: a proton MRS study. , 2005, Brain : a journal of neurology.

[19]  Ponnada A Narayana,et al.  Magnetic Resonance Spectroscopy in the Monitoring of Multiple Sclerosis , 2005, Journal of neuroimaging : official journal of the American Society of Neuroimaging.

[20]  B. Nan,et al.  MRI and 2D-CSI MR spectroscopy of the brain in the evaluation of patients with acute onset of neuropsychiatric systemic lupus erythematosus , 2005, Neuroradiology.

[21]  H. Petropoulos,et al.  Multisequence magnetic resonance imaging study of neuropsychiatric systemic lupus erythematosus. , 2004, Arthritis and rheumatism.

[22]  P. Bramanti,et al.  Straightforward relative quantitation and age-related human standards of N-acetylaspartate at the centrum semiovale level by CSI (1)H-MRS. , 2003, Magnetic resonance imaging.

[23]  G. Gronseth,et al.  Neuropsychiatric syndromes in lupus: Prevalence using standardized definitions , 2002, Neurology.

[24]  L. Vignolo,et al.  Prevalence and pattern of cognitive impairment in systemic lupus erythematosus patients with and without overt neuropsychiatric manifestations , 2001, Journal of the Neurological Sciences.

[25]  F. Howe,et al.  Sensitivity of quantitative 1H magnetic resonance spectroscopy of the brain in detecting early neuronal damage in systemic lupus erythematosus , 2001 .

[26]  J. Kang,et al.  Systemic lupus erythematosus: brain MR imaging and single-voxel hydrogen 1 MR spectroscopy. , 2000, Radiology.

[27]  Caroline Gordon,et al.  The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes. , 1999, Arthritis and rheumatism.

[28]  P. V. van Zijl,et al.  Neurochemistry of brain lesions determined by spectroscopic imaging in systemic lupus erythematosus. , 1997, The Journal of rheumatology.

[29]  M. Hochberg,et al.  Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. , 1997, Arthritis and rheumatism.

[30]  W M Brooks,et al.  Neurometabolism of active neuropsychiatric lupus determined with proton MR spectroscopy. , 1997, AJNR. American journal of neuroradiology.

[31]  D. Symmons,et al.  The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for systemic lupus erythematosus. , 1996, Arthritis and rheumatism.

[32]  S. Provencher.  Estimation of metabolite concentrations from localized in vivo proton NMR spectra , 1993, Magnetic resonance in medicine.

[33]  E. Schned,et al.  Derivation of the SLEDAI. , 1993, Arthritis and rheumatism.

[34]  D. Sackett,et al.  Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. , 1992, Arthritis and rheumatism.

[35]  R. Griffey,et al.  Magnetic resonance and computed tomographic imaging in the evaluation of acute neuropsychiatric disease in systemic lupus erythematosus. , 1989, Annals of the rheumatic diseases.

[36]  L. Jacobs,et al.  Central nervous system lupus erythematosus: the value of magnetic resonance imaging. , 1988, The Journal of rheumatology.

[37]  J F Fries,et al.  The 1982 revised criteria for the classification of systemic lupus erythematosus. , 1982, Arthritis and rheumatism.

[38]  S. Folstein,et al.  “Mini-mental state”: A practical method for grading the cognitive state of patients for the clinician , 1975 .

[39]  F. Cotton,et al.  [MRI of central nervous system in a series of 58 systemic lupus erythematosus (SLE) patients with or without overt neuropsychiatric manifestations]. , 2004, La Revue de medecine interne.

[40]  J. Woulfe,et al.  Hippocampal damage in mouse and human forms of systemic autoimmune disease , 2004, Hippocampus.

[41]  F. Cotton,et al.  Apport de l’IRM cérébrale dans une série de 58 cas de malade lupique avec ou sans manifestations neuropsychiatriques , 2004 .

[42]  I. Wilkinson,et al.  Magnetic resonance imaging of the brain and cerebral proton spectroscopy in patients with systemic lupus erythematosus. , 1997, Arthritis and rheumatism.

[43]  J. Sibley,et al.  The incidence and prognosis of central nervous system disease in systemic lupus erythematosus. , 1992, The Journal of rheumatology.